Timothy Pardee is an Oncology physician affiliated with Atrium Health Wake Forest Baptist. OpenAlex indexes 177 publications with 4,783 citations (h-index 34); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Blvd
Hanes Bld. Rm 4046
Winston Salem, NC 271570001
Telephone
336-716-5847Registry record last updated 8 Dec 2009.
Clinical trials
- Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
Sponsor: Timothy Pardee
- Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Sponsor: Wake Forest University Health Sciences
- Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ipsen InnovationProgram year20254 payments
- Syndax Pharmaceuticals, Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2012–2025 per NIH RePORTER. The latest:
- Developing Acute Myeloid Leukemia Models with Diverse Ancestral Origins
Wake Forest University Health Sciences
FY2025$177,249R21CA283135 - Translational Oncology Training Program
Wake Forest University Health Sciences
FY2024$266,711T32CA247819 - Developing Acute Myeloid Leukemia Models with Diverse Ancestral Origins
Wake Forest University Health Sciences
FY2024$213,594R21CA283135
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Leukemia & lymphoma/Leukemia and lymphoma
2024
Similar KOLs
Other experts from the same institution or the same specialty.
David Herrington, MD
Atrium Health Wake Forest Baptist
Bruce Lessey, MD
Atrium Health Wake Forest Baptist
David Hurd, MD
Atrium Health Wake Forest Baptist
Kevin High, MD
Atrium Health Wake Forest Baptist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”